Investigational drug for genetic form of ALS improves disease’s molecular signs
An international phase 3 clinical trial for a drug developed to treat a rare, inherited form of amyotrophic lateral sclerosis (ALS) showed that it reduced molecular signs of the fatal disease, but at six months did not improve motor control and muscle strength, according to Washington University School of Medicine researchers.
Siteman, University of Missouri to collaborate on cancer research, with aim to improve care
Siteman Cancer Center and the University of Missouri will collaborate on cancer research, with the aim to improve care throughout Missouri.
De Fer, Fraser honored by American College of Physicians
Thomas De Fer, MD, and Victoria J. Fraser, MD, both of the School of Medicine, have been awarded mastership in the American College of Physicians, one of the highest honors available to internists.
Gordon honored by National Academy of Medicine
Washington University School of Medicine’s Jeffrey Gordon, MD, has received the inaugural David and Beatrix Hamburg Award for Advances in Biomedical Research and Clinical Medicine from the National Academy of Medicine. Gordon is regarded as the father of the field of microbiome research.
Washington University Orthopedics teams up with St. Louis CITY Soccer Club
St. Louis CITY Soccer Club has chosen physicians with Washington University Orthopedics as the club’s official team doctors and BJC HealthCare as medical services provider.
Garcia to study neurological developmental disorder
Benjamin Garcia, the Raymond H. Wittcoff Distinguished Professor and head of the Department of Biochemistry and Molecular Biophysics at the School of Medicine, along with colleagues at the University of Pennsylvania, received a five-year $2.6 million grant from the National Institutes of Health (NIH) for a quantitative mass spectrometry project.
School of Medicine joins NIH initiative to expand use of AI in biomedical research
Washington University School of Medicine is joining the National Institutes of Health (NIH)’s Bridge2AI program, an estimated $130 million initiative. One project aims to develop a framework for using artificial intelligence to diagnose disease based on the sound of patients’ voices.
ICTS center launches program for minorities in research
A center in the Institute of Clinical and Translational Sciences received a grant establishing the School of Medicine as a coordinating center for the Short-Term Research Experience Program to Unlock Potential. STEP-UP is a National Institutes of Health (NIH) program to introduce scholars underrepresented in medicine to medical research.
Personalized prediction of depression treatment outcomes with wearables
Using Fitbits and a novel machine learning model, a multi-institutional team led by Washington University’s Chenyang Lu is ushering in the next step in personalization for treatment of depression.
Evaluation of AI for medical imaging: A key requirement for clinical translation
To develop guidelines to evaluate artificial intelligence (AI) in nuclear-medicine imaging, an interdisciplinary team established by Richard L. Wahl, MD, director of Mallinckrodt Institute of Radiology (MIR) and led by Abhinav Jha, assistant professor at the McKelvey School of Engineering, published Recommendations for Evaluation of AI for Nuclear Medicine in the Journal of Nuclear Medicine.
View More Stories